New research identifies modifiable risk factors for hea... (in heart function and blood vessel wall ...)

New research identifies modifiable risk factors for heart disease

Date:12/11/2009

in heart function and blood vessel wall thickness at two years compared with baseline measures. Whether the present findings translate into improved clinical outcomes requires further investigation.

More Intensive Cholesterol-Lowering Drugs Appear to Outshine Standard or Moderate Statin Therapy in the Prevention of Recurrent Cardiovascular Disease in Certain Patients; Stronger Statins Prevent Not Just First Heart Problem, but Also Second and Third Heart Attack

Two studies in this issue find that use of higher strength statin medications prevent not just a first cardiac event, but also a second or third event as well showing an even greater benefit of statin therapy than previously thought.

Data from over 14,000 patients from two large randomized lipid-lowering trials the Pravastin or Atorvastatin Evaluation and Infection Therapy-Thrombosis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Incremental Decreases in End Points through Aggressive Lipid Lowering (IDEAL) trials were analyzed in a new way to count the total number of heart problems. Traditionally, trials are analyzed based on the time to first cardiovascular event and, as a result, statistical analyses did not include subsequent cardiovascular events. Results from the expanded analyses of the PROVE-IT and IDEAL data found intensive statin therapy to be more effective than standard or moderate statin therapy in preventing additional atherosclerotic development and future cardiovascular events. When additional events are considered, the total number of events prevented by more intensive lipid-lowering therapy was substantially greater.

As previously reported by PROVE-IT, first primary end point events (death, heart attack, stroke, UA requiring rehospitalization, or revascularization) were reduced by 16 percent with atorvastatin 80 mg (intensive lipid lowering) versus pravastatin 40 mg (moderate lipid lowering) (n = 464 vs. n = 537, respectively; p = 0.005). When reexami
'/>"/>

Contact: Amanda Jekowsky
ajekowsk@acc.org
202-375-6645
American College of Cardiology
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
5. New research shows how chronic stress worsens neurodegenerative disease course
6. New research explores newborn in-hospital weight loss
7. Research may unlock mystery of autisms origin in the brain
8. Bipolar disorder relapses halved by Melbourne researchers
9. HIVs impact in Zimbabwe explored in new research
10. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
11. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find

Post Your Comments:

(Date:5/22/2013)... CORVALLIS, Ore. A new study shows there is ... self-control in American young children one that does ... In the United States, girls had higher levels of ... to control their behavior and impulses, follow directions, and ... academic performance and college completion, in past studies by ...

(Date:5/22/2013)... May 22, 2013 DePuy Pinnacle ... DePuy Pinnacle Hip Replacement System continue to move forward ... Bernstein Liebhard LLP reports. According to an Order ... to produce monitoring reports associated with a 2007 criminal ... device marketing practices. Plaintiffs maintained in their ...

(Date:5/22/2013)... Twenty student-led startup companies at Arizona ... an intensive startup accelerator designed to help them execute ... create local jobs as part of ASU’s Edson ... initiative offers approximately 20 student teams up to $20,000 ... to launch their for-profit, more-than-profit or nonprofit ventures. The ...

(Date:5/22/2013)... the next two decades, the cost of treating strokes ... double, topping more than $180 billion a year, according ... increase: an aging population. The report, from the American ... published May 22 in the journal Stroke . ... Dr. Bruce Ovbiagele, chairman of the department of neurology ...

(Date:5/22/2013)... New York (PRWEB) May 22, 2013 ... has established the Westchester Lung Nodule Center for ... or receive lung cancer care. Lung cancer is the deadliest ... year, more people in the U.S. die from lung cancer ... As with all cancers, early detection increases survival rates. ...

[0] 'Boys will be boys' in US, but not in Asia [0] DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort [0] Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report [0] Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care

... by the Public Campaign Action Fund: , To: Editorial Writers ... 27, 2009 , RE: The better way , ... by Common Cause and Public Campaign, two national organizations promoting comprehensive ... in drafting editorials. We will be sending out regular memos to ...

... SAN FRANCISCO, Oct. 27 Ghosts and goblins aren,t the ... by the Campaign for Safe Cosmetics reveals that popular children,s ... nickel, cobalt and chromium, which can cause lifelong skin sensitization ... listed on any of the product labels, so parents have ...

... ... in Fairfield, New Jersey is inviting trick-or-treaters to trade their candy for cash and prizes. ... , ... Dr. Jerry Strauss and the team at Aesthetic Dental Care, a practice offering cosmetic dentistry ...

... Science Center at Houston has been awarded a major grant ... to conduct innovative cancer research. The center will receive $2.4 ... $11.6 million over a 5-year period. The new center is ... is one of the first 12 Physical Sciences-Oncology Centers (PS-OCs) ...

... Health insurance, employee assistance could help mothers get treatment, ... More than 65 percent of U.S. mothers with depression ... , Black, Hispanic and other minority mothers are least ... are three times more likely to receive adequate treatment ...

... conjunction with National Respiratory Care Week, Contour Products(TM) , ... proud to promote the results of a 2009 survey conducted ... One of the most common issues among CPAP therapy users ... result of the mask pressing against their face. The ...

Cached Medicine News:Health News:The Better Way: Fair Elections Gains Momentum 2 Health News:The Better Way: Fair Elections Gains Momentum 3 Health News:Face Paints Laced With Toxic Heavy Metals 2 Health News:Fairfield, New Jersey Cosmetic Dentist Giving Back to U.S. Soldiers and Offering Cash for Candy this Halloween 2 Health News:Fairfield, New Jersey Cosmetic Dentist Giving Back to U.S. Soldiers and Offering Cash for Candy this Halloween 3 Health News:UT leads collaborative initiative for innovative cancer research 2 Health News:UT leads collaborative initiative for innovative cancer research 3 Health News:UT leads collaborative initiative for innovative cancer research 4 Health News:Depression Often Goes Untreated in Working Moms 2 Health News:Contour Products Promotes Survey for National Respiratory Care Week, Findings Prove Benefits of Contour CPAP Pillow for Sleep Apnea Patients 2 Health News:Contour Products Promotes Survey for National Respiratory Care Week, Findings Prove Benefits of Contour CPAP Pillow for Sleep Apnea Patients 3

The Better Way: Fair Elections Gains Momentum Face Paints Laced With Toxic Heavy Metals Fairfield, New Jersey Cosmetic Dentist Giving Back to U.S. Soldiers and Offering Cash for Candy this Halloween UT leads collaborative initiative for innovative cancer research Depression Often Goes Untreated in Working Moms Contour Products Promotes Survey for National Respiratory Care Week, Findings Prove Benefits of Contour CPAP Pillow for Sleep Apnea Patients

(Date:5/22/2013)... , May 22, 2013 Avanir Pharmaceuticals, Inc. (NASDAQ: ... an overview of the company at the following conferences. ... , Presentation date: Wednesday May 29, 2013 , Presentation ... Global Healthcare Conference , Presentation date: Wednesday June 5, ... A live webcast and 30-day archive ...

(Date:5/22/2013)... , May 22, 2013 Flagship Ventures, a ... on healthcare and sustainability, today announced the appointment ... a Senior Partner. In this role, Mr. Bancel ... companies. In addition to working closely ... also serves as President and Chief Executive Officer ...

(Date:5/22/2013)... -- Grifols, a global healthcare company based in ... demonstrating that a higher dose of PROLASTIN © -C ... alpha 1 protein in patients with alpha 1 ... the normal range for healthy individuals. AAT deficiency is ... the alpha 1 proteinase inhibitor (A1PI) protein can ...

Breaking Medicine Technology:Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2 Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2 Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3 Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2 Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3 Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4

[0] Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences [0] Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures [0] Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency

... ANN ARBOR, Mich., June 19 ... change interventions with outcomes, announced a,new research ... Insomnia and Overcoming(TM) Depression online behavior,change interventions ... Aetna,s,large employer members. Together, HealthMedia and Aetna ...

... safety and effectiveness of using cloned cells alone ... ... use of a human patient,s cloned infection-fighting T cells as,the sole therapy ... Cassian Yee, M.D., an associate member of the,Clinical Research Division at Fred ...

Cached Medicine Technology:HealthMedia and Aetna to Study Online Insomnia and Depression Interventions 2 HealthMedia and Aetna to Study Online Insomnia and Depression Interventions 3 HealthMedia and Aetna to Study Online Insomnia and Depression Interventions 4 Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation 2 Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation 3

HealthMedia and Aetna to Study Online Insomnia and Depression Interventions Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation

... The Acceava Mononucleosis test provides ... Mononucleosis with a simple procedure that ... Side-by-side evaluations with competitive products will ... These attributes enable you to deliver ...

... for the visual, qualitative detection ... infectious mononucleosis in human serum, ... This test is intended as ... of infectious mononucleosis in patients ...

The NOW® Flu B test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results an...

... Absorbable Hemostat is a purified and lyophilized ... a sponge-like pad, is lightly cross-linked, sterile, ... an inherent property of collagen, is largely ... this protein. The helical structure of native ...

Medicine Products:

The Acceava Mononucleosis test SureStep™ Mono Test NOW Flu B Test INSTAT Collagen Absorbable Hemostat